4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol,
hydroxyhaloperidol,
reduced haloperidol,
Reduced haloperidol,
Hydroxyhaloperidol,
34104-67-1,
HALOPERIDOL METABOLITE II,
CHEMBL1036,
MLS000069356,
WNZBBTJFOIOEMP-UHFFFAOYSA-N,
SMR000058675,
R 2572,
Dihydrohaloperidol,
Hydroxy-haloperidol,
Haloperidol (reduced),
AC1L3OHZ,
AC1Q4NNQ,
Opera_ID_1804,
UNII-D9M1Q7KW8U,
D9M1Q7KW8U,
MLS001148158,
SCHEMBL4540106,
HMS2234D04,
HMS3372K12,
BDBM50064946,
4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-hydroxybutyl)-4-piperidinol,
NCGC00018116-02,
LS-192366,
FT-0674336,
Haloperidol metabolite II, analytical standard,
J-019450,
1-(p-fluorophenyl)-4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-1 -butanol,
1-(p-fluorophenyl)-4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-1-butanol,
1-Piperidinebutanol, 4-(4-chlorophenyl)-alpha-(4-fluorophenyl)-4-hydroxy-,
4-(4-Chlorophenyl)-|A-(4-fluorophenyl)-4-hydroxy-1-piperidinebutanol,
4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-hydroxy-butyl]piperidin-4-ol,
4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-hydroxybutyl]piperidin-4-ol,
4-(4-chlorophenyl)-alpha-(4-fluorophenyl)-4-hydroxy-1-piperidinebutanol,
1-Piperidinebutanol, 4-(4-chlorophenyl)-.alpha.-(4-fluorophenyl)-4-hydroxy-,
1-Piperidinebutanol, 4-(4-chlorophenyl)-.alpha.-(4-fluorophenyl)-4-hydroxy-(R/S),
4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol,
4-(4-Chloro-phenyl)-1-[4-(4-fluoro-phenyl)-4-hydroxy-butyl]-piperidin-4-ol,
( inverted exclamation markA)-4-(4-Chlorophenyl)-|A-(4-fluorophenyl)-4-hydroxy-1-piperidinebutanol,
C21H25ClFNO2,
C21-H25-Cl-F-N-O2,
AR-1F6240,
CID119265,
136271-60-8,
35285-54-2,